SCHEMBL21699096

SCHEMBL21699096

Cc1ccc2cc(N)c(C(=O)O)cc2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.65
▸ KMT2A Q03164 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ CA12 O43570 1/20 0.49
▸ CA1 P00915 1/20 0.49
▸ CA2 P00918 1/20 0.49
▸ CA4 P22748 1/20 0.49
▸ CA6 P23280 1/20 0.49
▸ MAOB P27338 1/20 0.49
▸ CA5A P35218 1/20 0.49
▸ CA7 P43166 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ CA14 Q9ULX7 1/20 0.49
▸ CA5B Q9Y2D0 1/20 0.49
▸ CSNK2A1 P68400 1/20 0.47
▸ CYP2A6 P11509 4/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ KDM4E B2RXH2 4/20 0.44
▸ GFER P55789 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15133540 0.82 IDO1 (0.75) IDO1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL15131699 0.81 IDO1 (0.69) IDO1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL30156557 0.81 IDO1 (0.69) IDO1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL14963070 0.81 IDO1 (0.54) IDO1KMT2AMEN1ALDH1A1CYP1A2
SCHEMBL24895084 0.80 CSNK2A1 (0.63) KMT2AMEN1ALDH1A1CA12CA1
SCHEMBL4609751 0.80 CSNK2A1 (0.63) KMT2AMEN1ALDH1A1CA12CA1
SCHEMBL8960584 0.80 IDO1 (0.67) IDO1KMT2AMEN1ALDH1A1KDM4E
SCHEMBL221528 0.79 KMT2A (0.63) IDO1KMT2AMEN1ALDH1A1CSNK2A1
SCHEMBL283554 0.79 CSNK2A1 (0.55) IDO1KMT2AMEN1ALDH1A1CSNK2A1
SCHEMBL8006518 0.79 IDO1 (1.00) IDO1KMT2AMEN1ALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370733-B2 Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object CANON KABUSHIKI KAISHA (JP) 2022-06-28 — — US disclosed
US-20200048171-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT CANON KABUSHIKI KAISHA (JP) 2020-02-13 — — US disclosed
EP-3608303-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT CANON KABUSHIKI KAISHA (JP) 2020-02-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048171-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOVING OBJECT OCIAD1, L1CAM, SPIN4 IDO1 1803/4885KMT2A 2177/4885MEN1 1244/4885
US-11370733-B2 Organic compound, organic light-emitting element, display device, imaging device, electronic device, illumination device, and moving object OCIAD1, L1CAM, SPIN4 IDO1 1803/4885KMT2A 2177/4885MEN1 1244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback